Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1974 1
1978 1
1979 3
1980 3
1981 3
1982 4
1983 6
1984 9
1985 6
1986 9
1987 4
1988 8
1989 3
1990 9
1991 3
1992 5
1993 3
1994 1
1995 1
1996 3
1999 1
2000 2
2001 1
2002 2
2003 1
2004 1
2006 2
2007 2
2009 2
2010 6
2011 4
2012 9
2013 12
2014 15
2015 11
2016 7
2017 18
2018 11
2019 13
2020 20
2021 26
2022 16
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Results by year

Filters applied: . Clear all
Page 1
Parkinson Matters.
Darweesh SKL, Raphael KG, Brundin P, Matthews H, Wyse RK, Chen H, Bloem BR. Darweesh SKL, et al. Among authors: wyse rk. J Parkinsons Dis. 2018;8(4):495-498. doi: 10.3233/JPD-181374. J Parkinsons Dis. 2018. PMID: 30149463 Free PMC article.
GLP-1 receptor agonists for Parkinson's disease.
Mulvaney CA, Duarte GS, Handley J, Evans DJ, Menon S, Wyse R, Emsley HC. Mulvaney CA, et al. Among authors: wyse r. Cochrane Database Syst Rev. 2020 Jul 23;7(7):CD012990. doi: 10.1002/14651858.CD012990.pub2. Cochrane Database Syst Rev. 2020. PMID: 32700772 Free PMC article.
Trial of Lixisenatide in Early Parkinson's Disease.
Meissner WG, Remy P, Giordana C, Maltête D, Derkinderen P, Houéto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrière N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O; LIXIPARK Study Group. Meissner WG, et al. Among authors: wyse rk. N Engl J Med. 2024 Apr 4;390(13):1176-1185. doi: 10.1056/NEJMoa2312323. N Engl J Med. 2024. PMID: 38598572 Clinical Trial.
Statins and Parkinson's: A complex interaction.
Carroll CB, Wyse RKH, Grosset DG. Carroll CB, et al. Among authors: wyse rkh. Mov Disord. 2019 Jul;34(7):934-935. doi: 10.1002/mds.27721. Mov Disord. 2019. PMID: 31322771 No abstract available.
Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative.
Gonzalez-Robles C, Weil RS, van Wamelen D, Bartlett M, Burnell M, Clarke CS, Hu MT, Huxford B, Jha A, Lambert C, Lawton M, Mills G, Noyce A, Piccini P, Pushparatnam K, Rochester L, Siu C, Williams-Gray CH, Zeissler ML, Zetterberg H, Carroll CB, Foltynie T, Schrag A; EJS ACT-PD Consortium. Gonzalez-Robles C, et al. J Parkinsons Dis. 2023;13(6):1011-1033. doi: 10.3233/JPD-230051. J Parkinsons Dis. 2023. PMID: 37545260 Free PMC article. Clinical Trial.
Seeking progress in disease modification in Parkinson disease.
Lungu C, Cedarbaum JM, Dawson TM, Dorsey ER, Faraco C, Federoff HJ, Fiske B, Fox R, Goldfine AM, Kieburtz K, Macklin EA, Matthews H, Rafaloff G, Saunders-Pullman R, Schor NF, Schwarzschild MA, Sieber BA, Simuni T, Surmeier DJ, Tamiz A, Werner MH, Wright CB, Wyse R. Lungu C, et al. Among authors: wyse r. Parkinsonism Relat Disord. 2021 Sep;90:134-141. doi: 10.1016/j.parkreldis.2021.09.006. Epub 2021 Sep 10. Parkinsonism Relat Disord. 2021. PMID: 34561166 Review.
266 results